Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Genetics

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 47 articles: HTML format

Single Articles

April 2024
1. MAURA F, Rajanna AR, Ziccheddu B, Poos AM, et al
   Genomic Classification and Individualized Prognosis in Multiple Myeloma.
   J Clin Oncol. 2024;42:1229-1240.
   PubMed     Abstract available
   
   
   
2. SHRIVER SP, Adams D, McKelvey BA, McCune JS, et al
   Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
   J Clin Oncol. 2024;42:1181-1192.
   PubMed     Abstract available
   
   
   February 2024
3. TRAVIS LB, Feldman DR, Fung C, Poynter JN, et al
   Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.
   J Clin Oncol. 2024;42:696-706.
   PubMed     Abstract available
   
   
   January 2024
4. RICCIUTI B, Lamberti G, Puchala SR, Mahadevan NR, et al
   Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2024 Jan 11:JCO2300580. doi: 10.1200/JCO.23.00580.
   PubMed     Abstract available
   
   
   December 2023
5. JAGSI R, Griffith KA, Harris EE, Wright JL, et al
   Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
   J Clin Oncol. 2023 Dec 7:JCO2302270. doi: 10.1200/JCO.23.02270.
   PubMed     Abstract available
   
   
   November 2023
6. MANDELKER D, Marra A, Zheng-Lin B, Selenica P, et al
   Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
   J Clin Oncol. 2023;41:5151-5162.
   PubMed     Abstract available
   
   
   
7. KILBRIDE M, Egleston BL, Chung WK, Olopade O, et al
   Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.
   J Clin Oncol. 2023;41:4905-4915.
   PubMed     Abstract available
   
   
   August 2023
8. NARDONE V, Meirson T, De Felice F, Meattini I, et al
   Genomic Profiling: Can We Rely on Retrospective Analysis to Drive Changes in Clinical Practice?
   J Clin Oncol. 2023;41:3957-3958.
   PubMed    
   
   
   
9. ANDO Y, Terada T
   Consent in Pharmacogenetic Testing.
   J Clin Oncol. 2023;41:3875.
   PubMed    
   
   
   July 2023
10. STRACH MC, Mahon K, Barriuso J
    Genomic Subtypes of Appendiceal Adenocarcinoma: Enough to Guide Clinical Decision Making?
    J Clin Oncol. 2023;41:3559.
    PubMed    
    
    
    June 2023
11. SUBBIAH V, Kurzrock R
    Universal Germline and Tumor Genomic Testing Needed to Win the War Against Cancer: Genomics Is the Diagnosis.
    J Clin Oncol. 2023;41:3100-3103.
    PubMed    
    
    
    May 2023
12. KINNEY AY, Walters ST, Lin Y, Lu SE, et al
    Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
    J Clin Oncol. 2023;41:2767-2778.
    PubMed     Abstract available
    
    
    February 2023
13. CHUNG J, Negm L, Bianchi V, Stengs L, et al
    Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.
    J Clin Oncol. 2023;41:766-777.
    PubMed     Abstract available
    
    
    January 2023
14. YU Y, Shi Q, Chen H
    Acquired Genomic Alterations From First-Line Anti-EGFR Chemotherapy in Advanced Colorectal Cancer: Improving Study Design and Data Analysis.
    J Clin Oncol. 2023 Jan 3:JCO2202296. doi: 10.1200/JCO.22.02296.
    PubMed    
    
    
    December 2022
15. FREY MK, Ahsan MD, Bergeron H, Lin J, et al
    Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
    J Clin Oncol. 2022;40:4129-4143.
    PubMed     Abstract available
    
    
    September 2022
16. RAGHAV K, Ou FS, Venook AP, Innocenti F, et al
    Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance).
    J Clin Oncol. 2022 Sep 6:JCO2200365. doi: 10.1200/JCO.22.00365.
    PubMed     Abstract available
    
    
    July 2022
17. JOHANSSON A, Dar H, van 't Veer LJ, Tobin NP, et al
    Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.
    J Clin Oncol. 2022 Jul 21:JCO2102844. doi: 10.1200/JCO.21.02844.
    PubMed     Abstract available
    
    
    
18. LEE CH, Voss MH, Carlo MI, Chen YB, et al
    Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell Renal Cell Carcinoma and Genomic Correlates.
    J Clin Oncol. 2022;40:2333-2341.
    PubMed     Abstract available
    
    
    June 2022
19. HOL JA, Kuiper RP, van Dijk F, Waanders E, et al
    Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.
    J Clin Oncol. 2022;40:1892-1902.
    PubMed     Abstract available
    
    
    
20. GWEE YX, Chia DKA, So J, Ceelen W, et al
    Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.
    J Clin Oncol. 2022 Jun 1:JCO2102745. doi: 10.1200/JCO.21.02745.
    PubMed     Abstract available
    
    
    April 2022
21. KURRECK A, Stintzing S, Modest DP
    Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?
    J Clin Oncol. 2022;40:1260-1262.
    PubMed    
    
    
    
22. CHAKRAVARTY D, Johnson A, Sklar J, Lindeman NI, et al
    Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion.
    J Clin Oncol. 2022;40:1231-1258.
    PubMed     Abstract available
    
    
    February 2022
23. CARLOS RC, Obeng-Gyasi S, Cole SW, Zebrack BJ, et al
    Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach.
    J Clin Oncol. 2022 Feb 2:JCO2102004. doi: 10.1200/JCO.21.02004.
    PubMed    
    
    
    December 2021
24. SABNIS HS, Shulman DS, Mizukawa B, Bouvier N, et al
    Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
    J Clin Oncol. 2021;39:3822-3828.
    PubMed     Abstract available
    
    
    November 2021
25. NAZHA A, Komrokji R, Meggendorfer M, Jia X, et al
    Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:3737-3746.
    PubMed     Abstract available
    
    
    October 2021
26. ADEMUYIWA FO, Salyer P, Tao Y, Luo J, et al
    Genetic Counseling and Testing in African American Patients With Breast Cancer: A Nationwide Survey of US Breast Oncologists.
    J Clin Oncol. 2021 Oct 18:JCO2101426. doi: 10.1200/JCO.21.01426.
    PubMed     Abstract available
    
    
    September 2021
27. MASCARENHAS L
    A Step Forward in Realizing the Promise of Genomic Medicine for Childhood Rhabdomyosarcoma.
    J Clin Oncol. 2021;39:2851-2854.
    PubMed    
    
    
    
28. SHERN JF, Selfe J, Izquierdo E, Patidar R, et al
    Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    J Clin Oncol. 2021;39:2859-2871.
    PubMed     Abstract available
    
    
    April 2021
29. BERSANELLI M, Travaglino E, Meggendorfer M, Matteuzzi T, et al
    Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
    J Clin Oncol. 2021;39:1223-1233.
    PubMed     Abstract available
    
    
    
30. MURPHY AB, Abern MR, Liu L, Wang H, et al
    Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial.
    J Clin Oncol. 2021 Apr 9:JCO2002997. doi: 10.1200/JCO.20.02997.
    PubMed     Abstract available
    
    
    February 2021
31. CREW KD, Hershman DL
    Better Together: Clinical and Genomic Data to Inform Shared Decision Making.
    J Clin Oncol. 2021;39:545-547.
    PubMed    
    
    
    January 2021
32. KUMAR R, Smith KS, Deng M, Terhune C, et al
    Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    J Clin Oncol. 2021 Jan 27:JCO2001359. doi: 10.1200/JCO.20.01359.
    PubMed     Abstract available
    
    
    
33. KALINSKY K, Thomas A, Cescon DW
    On the Road to Precision: Understanding the Biology Driving Genomic Assays.
    J Clin Oncol. 2021;39:100-102.
    PubMed    
    
    
    
34. GAJJAR A, Robinson GW, Smith KS, Lin T, et al
    Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).
    J Clin Oncol. 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
    PubMed     Abstract available
    
    
    November 2020
35. AMBROS IM, Tonini GP, Potschger U, Gross N, et al
    Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
    J Clin Oncol. 2020;38:3685-3697.
    PubMed     Abstract available
    
    
    October 2020
36. CROMBIE JL, Armand P
    Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm.
    J Clin Oncol. 2020;38:3565-3574.
    PubMed    
    
    
    July 2020
37. LONIAL S, Dhodapkar MV, Rajkumar SV
    Smoldering Myeloma and the Art of War.
    J Clin Oncol. 2020;38:2363-2365.
    PubMed    
    
    
    
38. BUSTOROS M, Sklavenitis-Pistofidis R, Park J, Redd R, et al
    Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
    J Clin Oncol. 2020;38:2380-2389.
    PubMed     Abstract available
    
    
    May 2020
39. LIN DW, Zheng Y, McKenney JK, Brown MD, et al
    17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort.
    J Clin Oncol. 2020;38:1549-1557.
    PubMed     Abstract available
    
    
    
40. KURIAN AW, Katz SJ
    Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control.
    J Clin Oncol. 2020;38:1371-1374.
    PubMed    
    
    
    
41. FREY MK, Kahn RM, Chapman-Davis E, Tubito F, et al
    Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.
    J Clin Oncol. 2020;38:1389-1397.
    PubMed     Abstract available
    
    
    April 2020
42. ROBINSON GW, Gajjar A
    Genomics Paves the Way for Better Infant Medulloblastoma Therapy.
    J Clin Oncol. 2020 Apr 30:JCO2000593. doi: 10.1200/JCO.20.00593.
    PubMed    
    
    
    
43. TREON SP, Xu L, Guerrera ML, Jimenez C, et al
    Genomic Landscape of Waldenstrom Macroglobulinemia and Its Impact on Treatment Strategies.
    J Clin Oncol. 2020;38:1198-1208.
    PubMed     Abstract available
    
    
    March 2020
44. FREEMAN S, Craddock C
    Less Is Not Necessarily More: Toward a Rational Selection of the Conditioning Regimen in Acute Myeloid Leukemia.
    J Clin Oncol. 2020 Mar 2:JCO1903161. doi: 10.1200/JCO.19.03161.
    PubMed    
    
    
    February 2020
45. HASSETT MJ, Somerfield MR, Baker ER, Cardoso F, et al
    Management of Male Breast Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Feb 14:JCO1903120. doi: 10.1200/JCO.19.03120.
    PubMed     Abstract available
    
    
    January 2020
46. KONSTANTINOPOULOS PA, Norquist B, Lacchetti C, Armstrong D, et al
    Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    J Clin Oncol. 2020 Jan 27:JCO1902960. doi: 10.1200/JCO.19.02960.
    PubMed     Abstract available
    
    
    December 2019
47. EGGENER SE, Rumble RB, Armstrong AJ, Morgan TM, et al
    Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.
    J Clin Oncol. 2019 Dec 12:JCO1902768. doi: 10.1200/JCO.19.02768.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge.